New Treatment Approaches Valuable For Cancer Pain, Quality Of Life
High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer
Implantable Drug Delivery Device Offers Better Pain Relief
New Drug Reverses Damage To Liver In Stem Cell Transplant
New Approach To Replacing Immune Cells Shrinks Tumors
IL13-PE38 Looks Promising In Early Tests Against Gioma
US Oncology Begins Trial Of Taxotere And Xeloda
Clinical Trials Approved In August 2002 By NCI
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore









